Webcast

Competing in the Global Marketplace

Duration: 2.5 hours
ISPE CEUs: 0.2

 Purchase from ISPE's Online Store

This session challenges the current state of the pharmaceutical industry with these provocative questions.

• Is risk-adversity suicide in the face of competition? Change is essential, yet numerous companies avoid change because it comes with risk.
• Why build more and more elaborate facilities using more and more energy?
• Why use equipment and processes a baker in the 1900s would recognize?
• Why believe the regulator is the enemy?
• Why do we still find silos when quality, regulatory, toxicology, validation, and others rarely talk to each other?

How You Will Benefit

At the end of this session, participants will be able to:

• Understand the issues that delegates raise as most challenging
• Become open to possible new solutions
• Create change or at least start the discussion

Who Should Attend

Senior management and decision makers

Session Leader

Julian Wilkins, Vice President, PharmaConsult US Inc, USA

Session Speakers

Ali Afnan, Senior Staff Fellow, FDA/CDER, USA
John Fielding, Senior Director, Genentech, USA
Russ Somma, President, SommaTech, LLC, USA

Related Communities of Practice (COPs)
All

More information on Communities of Practice (COPs)

Continuing Education Units or CEUs are a way to document time spent in educational programs. ISPE CEUs are calculated as follows: 1 CEU = 10 hours of education time. Thus 0.1 CEU is equal to one hour of education. Download a form to apply for the CEUs for this program.